Abstract
We prepared 13 derivatives of N-(biphenyl-4′-yl)methyl (R)-2-acetamido-3-methoxypropionamide that differed in type and placement of a R-substituent in the terminal aryl unit. We demonstrated that the R-substituent impacted the compound's whole animal and cellular pharmacological activities. In rodents, select compounds exhibited excellent anticonvulsant activities and protective indices (PI = TD50/ED50) that compared favorably with clinical antiseizure drugs. Compounds with a polar, aprotic R-substituent potently promoted Na+ channel slow inactivation and displayed frequency (use) inhibition of Na+ currents at low micromolar concentrations. The possible advantage of affecting these two pathways to decrease neurological hyperexcitability is discussed.
Original language | English (US) |
---|---|
Pages (from-to) | 6165-6182 |
Number of pages | 18 |
Journal | Journal of Medicinal Chemistry |
Volume | 57 |
Issue number | 14 |
DOIs | |
State | Published - Jul 24 2014 |
ASJC Scopus subject areas
- Molecular Medicine
- Drug Discovery